Mirum Pharmaceuticals, Inc. (MIRM)
96.74
+0.44
(+0.45%)
USD |
NASDAQ |
Aug 24, 16:00
96.74
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Total Assets (Quarterly) : 1.045B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.045B |
| March 31, 2026 | 890.92M |
| December 31, 2025 | 842.81M |
| September 30, 2025 | 785.12M |
| June 30, 2025 | 725.82M |
| March 31, 2025 | 690.24M |
| December 31, 2024 | 670.75M |
| September 30, 2024 | 667.89M |
| June 30, 2024 | 660.75M |
| March 31, 2024 | 651.96M |
| December 31, 2023 | 646.62M |
| September 30, 2023 | 650.64M |
| June 30, 2023 | 443.59M |
| March 31, 2023 | 333.53M |
| December 31, 2022 | 352.91M |
| Date | Value |
|---|---|
| September 30, 2022 | 364.35M |
| June 30, 2022 | 297.23M |
| March 31, 2022 | 278.15M |
| December 31, 2021 | 294.65M |
| September 30, 2021 | 235.17M |
| June 30, 2021 | 247.67M |
| March 31, 2021 | 222.24M |
| December 31, 2020 | 240.86M |
| September 30, 2020 | 141.86M |
| June 30, 2020 | 155.77M |
| March 31, 2020 | 172.80M |
| December 31, 2019 | 146.71M |
| September 30, 2019 | 158.27M |
| June 30, 2019 | 104.27M |
| March 31, 2019 | 51.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Incyte Corp. | 7.873B |
| Insmed, Inc. | 2.103B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| BioMarin Pharmaceutical, Inc. | 11.72B |
| Ionis Pharmaceuticals, Inc. | 2.995B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.055B |
| Shareholders Equity (Quarterly) | -10.42M |
| Debt to Equity Ratio | -73.21 |
| Current Ratio | 2.856 |
| Net Debt Paydown Yield | -1.18% |